29/12/2009
Cell Therapeutics, Inc.
SEATTLE, Dec. 28 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that on December 24, 2009, CTI's Board of Directors (the "Board of Directors") rejected and dropped a Shareholder Rights Plan (the "Rights Plan") in which one preferred stock purchase right could be distributed for each common share held as of the close of business on January 7, 2010. Initially, the rights are exercisable, and are attached to and trade with, all of the shares of CTI's common stock outstanding as of, and issued subsequent to, the record date.
Subscribe to:
Post Comments (Atom)
SOUTH AFRICA SPRINGBOKS
South Africa laid the groundwork with traditional Springbok rugby and finished an out-gunned England side off with two late tries to win ...
-
That the Chinese used oil from natural seeps as fuel to boil salt brine into salt. Initially bamboo was pounded vertically into oil containi...
-
The crude Saga continues with the price reaching the $117,60 a barrel...due to OPEP speculation and greed ... All OPEC members have shown th...
-
As predicted by WorldWatch some time back and now confirmed by the International Energy Agency (IEA) a 3% global crude demand is expected th...
No comments:
Post a Comment